-
Je něco špatně v tomto záznamu ?
Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus
J. Pokorná, P. Pachl, E. Karlukova, J. Hejdánek, P. Řezáčová, A. Machara, J. Hudlický, J. Konvalinka, M. Kožíšek,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
29933553
DOI
10.3390/v10070339
Knihovny.cz E-zdroje
- MeSH
- antivirové látky farmakologie MeSH
- chřipka lidská virologie MeSH
- inhibitory enzymů farmakologie MeSH
- kalorimetrie MeSH
- kinetika MeSH
- krystalizace MeSH
- lidé MeSH
- missense mutace MeSH
- neuraminidasa chemie genetika MeSH
- oseltamivir farmakologie MeSH
- replikace viru MeSH
- substituce aminokyselin MeSH
- termodynamika MeSH
- virová léková rezistence genetika MeSH
- virové proteiny chemie genetika MeSH
- virus chřipky A, podtyp H1N1 účinky léků enzymologie genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Neuraminidase is the main target for current influenza drugs. Reduced susceptibility to oseltamivir, the most widely prescribed neuraminidase inhibitor, has been repeatedly reported. The resistance substitutions I223V and S247N, alone or in combination with the major oseltamivir-resistance mutation H275Y, have been observed in 2009 pandemic H1N1 viruses. We overexpressed and purified the ectodomain of wild-type neuraminidase from the A/California/07/2009 (H1N1) influenza virus, as well as variants containing H275Y, I223V, and S247N single mutations and H275Y/I223V and H275Y/S247N double mutations. We performed enzymological and thermodynamic analyses and structurally examined the resistance mechanism. Our results reveal that the I223V or S247N substitution alone confers only a moderate reduction in oseltamivir affinity. In contrast, the major oseltamivir resistance mutation H275Y causes a significant decrease in the enzyme’s ability to bind this drug. Combination of H275Y with an I223V or S247N mutation results in extreme impairment of oseltamivir’s inhibition potency. Our structural analyses revealed that the H275Y substitution has a major effect on the oseltamivir binding pose within the active site while the influence of other studied mutations is much less prominent. Our crystal structures also helped explain the augmenting effect on resistance of combining H275Y with both substitutions.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012595
- 003
- CZ-PrNML
- 005
- 20190408082216.0
- 007
- ta
- 008
- 190405s2018 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/v10070339 $2 doi
- 035 __
- $a (PubMed)29933553
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Pokorná, Jana $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. jana.pokorna@uochb.cas.cz.
- 245 10
- $a Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus / $c J. Pokorná, P. Pachl, E. Karlukova, J. Hejdánek, P. Řezáčová, A. Machara, J. Hudlický, J. Konvalinka, M. Kožíšek,
- 520 9_
- $a Neuraminidase is the main target for current influenza drugs. Reduced susceptibility to oseltamivir, the most widely prescribed neuraminidase inhibitor, has been repeatedly reported. The resistance substitutions I223V and S247N, alone or in combination with the major oseltamivir-resistance mutation H275Y, have been observed in 2009 pandemic H1N1 viruses. We overexpressed and purified the ectodomain of wild-type neuraminidase from the A/California/07/2009 (H1N1) influenza virus, as well as variants containing H275Y, I223V, and S247N single mutations and H275Y/I223V and H275Y/S247N double mutations. We performed enzymological and thermodynamic analyses and structurally examined the resistance mechanism. Our results reveal that the I223V or S247N substitution alone confers only a moderate reduction in oseltamivir affinity. In contrast, the major oseltamivir resistance mutation H275Y causes a significant decrease in the enzyme’s ability to bind this drug. Combination of H275Y with an I223V or S247N mutation results in extreme impairment of oseltamivir’s inhibition potency. Our structural analyses revealed that the H275Y substitution has a major effect on the oseltamivir binding pose within the active site while the influence of other studied mutations is much less prominent. Our crystal structures also helped explain the augmenting effect on resistance of combining H275Y with both substitutions.
- 650 _2
- $a substituce aminokyselin $7 D019943
- 650 _2
- $a antivirové látky $x farmakologie $7 D000998
- 650 _2
- $a kalorimetrie $7 D002151
- 650 _2
- $a krystalizace $7 D003460
- 650 _2
- $a virová léková rezistence $x genetika $7 D024882
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a virus chřipky A, podtyp H1N1 $x účinky léků $x enzymologie $x genetika $7 D053118
- 650 _2
- $a chřipka lidská $x virologie $7 D007251
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a missense mutace $7 D020125
- 650 _2
- $a neuraminidasa $x chemie $x genetika $7 D009439
- 650 _2
- $a oseltamivir $x farmakologie $7 D053139
- 650 _2
- $a termodynamika $7 D013816
- 650 _2
- $a virové proteiny $x chemie $x genetika $7 D014764
- 650 _2
- $a replikace viru $7 D014779
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pachl, Petr $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. petr.pachl@uochb.cas.cz.
- 700 1_
- $a Karlukova, Elena $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. karlukova@email.cz. Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Technická 5, 166 28 Prague 6, Czech Republic. karlukova@email.cz.
- 700 1_
- $a Hejdánek, Jakub $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. jakub.hejdanek@uochb.cas.cz. Department of Biochemistry, Faculty of Science, Charles University, Hlavova 8, 128 00 Prague 2, Czech Republic. jakub.hejdanek@uochb.cas.cz.
- 700 1_
- $a Řezáčová, Pavlína $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. pavlina.rezacova@uochb.cas.cz. The Czech Academy of Sciences, Institute of Molecular Genetics, Vídeňská 1083, 140 00 Prague 4, Czech Republic. pavlina.rezacova@uochb.cas.cz.
- 700 1_
- $a Machara, Aleš $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. ales.machara@uochb.cas.cz. Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 00 Prague 2, Czech Republic. ales.machara@uochb.cas.cz.
- 700 1_
- $a Hudlický, Jason $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. j.r.hudlicky@gmail.com. Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 00 Prague 2, Czech Republic. j.r.hudlicky@gmail.com.
- 700 1_
- $a Konvalinka, Jan $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. jan.konvalinka@uochb.cas.cz. Department of Biochemistry, Faculty of Science, Charles University, Hlavova 8, 128 00 Prague 2, Czech Republic. jan.konvalinka@uochb.cas.cz.
- 700 1_
- $a Kožíšek, Milan $u The Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo n. 2, 166 10 Prague 6, Czech Republic. milan.kozisek@uochb.cas.cz.
- 773 0_
- $w MED00177099 $t Viruses $x 1999-4915 $g Roč. 10, č. 7 (2018)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29933553 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190408082229 $b ABA008
- 999 __
- $a ok $b bmc $g 1391905 $s 1050900
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 10 $c 7 $e 20180621 $i 1999-4915 $m Viruses $n Viruses $x MED00177099
- LZP __
- $a Pubmed-20190405